(guselkumab)
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
Last Updated: 10/10/2024
However, we cannot guarantee that the excipients do not come in contact with latex during the manufacturing or packaging process (eg, latex gloves).1
1 | Data on File. Technical document - patient safety and compliance information of TREMFYA (guselkumab) 100 mg/mL and guselkumab Crohn’s disease PFS 2 mL (200 mg) and 200 mg FVP v6. Janssen Material Sciences; 2024. |